OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
22
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Metabolomics
(1)
Repository
MetaboLights
(1)
Technology Type
Mass spectrometry
(1)
Instrument Platform
Liquid Chromatography MS - positive - reverse phase
(1)
Publication Date
2019
(1)
CHEBI ID
CHEBI:10023
(1)
CHEBI:10033
(1)
CHEBI:10102
(1)
CHEBI:101096
(1)
CHEBI:10110
(1)
CHEBI:10125
(1)
CHEBI:101278
(1)
CHEBI:107736
(1)
CHEBI:134851
(1)
CHEBI:135005
(1)
CHEBI:135587
(1)
CHEBI:135720
(1)
CHEBI:142290
(1)
CHEBI:174690
(1)
CHEBI:17486
(1)
CHEBI:179557
(1)
CHEBI:18358
(1)
CHEBI:223316
(1)
CHEBI:23359
(1)
CHEBI:2361
(1)
CHEBI:2379
(1)
CHEBI:2618
(1)
CHEBI:2704
(1)
CHEBI:27779
(1)
CHEBI:27796
(1)
CHEBI:28241
(1)
CHEBI:28487
(1)
CHEBI:28544
(1)
CHEBI:28876
(1)
CHEBI:2904
(1)
Metabolite Name
Acecainide
(1)
Artemisinin
(1)
Bisacodyl
(1)
Bromocriptine mesylate
(1)
Camylofine dihydrochloride
(1)
Carbetapentane citrate
(1)
FEBUXOSTAT
(1)
FENOFIBRATE
(1)
FEXOFENADINE
(1)
FINASTERIDE
(1)
FLUCONAZOLE
(1)
FLUOXETINE
(1)
FLUPHENAZINE
(1)
FLUVOXAMINE MALEATE
(1)
GALANTAMINE
(1)
GLICLAZIDE
(1)
GLIPIZIDE
(1)
GRISEOFULVIN
(1)
GUANFACINE
(1)
HALOPERIDOL
(1)
HYOSCYAMINE
(1)
IDEBENONE
(1)
IMATINIB
(1)
INDAPAMIDE
(1)
INDOMETHACIN
(1)
IRBESARTAN
(1)
IRSOGLADINE MALEATE
(1)
ISRADIPINE
(1)
ITRACONAZOLE
(1)
KETOROLAC TROMETHAMINE
(1)
Release Date
2014
(5)
2020
(3)
2018
(3)
2022
(2)
2019
(2)
2024
(1)
2023
(1)
2021
(1)
2017
(1)
2016
(1)
2015
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
Coupling of Charge Regulation and Conformational Equilibria in Linear Weak Polyelectrolytes: Treatment of Long-Range Interactions via Effective Short-Ranged and pH-Dependent Interaction Parameters.
Not available
S-EPMC6403780
|
biostudies-literature
Cite
Alkalosis-induced hypoventilation in cystic fibrosis: The importance of efficient renal adaptation.
Not available
S-EPMC8872776
|
biostudies-literature
Cite
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial.
Not available
S-EPMC5966023
|
biostudies-literature
Cite
Applying the Human Appropriation of Net Primary Production framework to map provisioning ecosystem services and their relation to ecosystem functioning across the European Union.
Not available
S-EPMC8491453
|
biostudies-literature
Cite
Unveiling the potential for an efficient use of nitrogen along the food supply and consumption chain.
Not available
S-EPMC7299078
|
biostudies-literature
Cite
Complementing the topsoil information of the Land Use/Land Cover Area Frame Survey (LUCAS) with modelled N2O emissions.
Not available
S-EPMC5407635
|
biostudies-literature
Cite
Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study.
Not available
S-EPMC4260032
|
biostudies-literature
Cite
Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib.
Not available
S-EPMC5303616
|
biostudies-literature
Cite
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors.
Not available
S-EPMC5132035
|
biostudies-literature
Cite
Efficacy and safety of bosutinib in previously treated patients with chronic myeloid leukemia: final results from the BYOND trial.
Not available
S-EPMC11436368
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets